1. Home
  2. SOS vs BFRI Comparison

SOS vs BFRI Comparison

Compare SOS & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOS Limited

SOS

SOS Limited

HOLD

Current Price

$1.39

Market Cap

10.7M

Sector

Finance

ML Signal

HOLD

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$0.81

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOS
BFRI
Founded
2004
1997
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7M
9.7M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
SOS
BFRI
Price
$1.39
$0.81
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.75
AVG Volume (30 Days)
43.6K
103.6K
Earning Date
09-26-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$260,505,000.00
$37,164,000.00
Revenue This Year
N/A
$9.70
Revenue Next Year
N/A
$10.97
P/E Ratio
N/A
N/A
Revenue Growth
134.43
5.11
52 Week Low
$1.02
$0.54
52 Week High
$9.62
$1.87

Technical Indicators

Market Signals
Indicator
SOS
BFRI
Relative Strength Index (RSI) 50.59 41.71
Support Level $1.29 $0.77
Resistance Level $1.56 $0.83
Average True Range (ATR) 0.11 0.05
MACD 0.04 0.01
Stochastic Oscillator 65.56 39.27

Price Performance

Historical Comparison
SOS
BFRI

About SOS SOS Limited

SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Share on Social Networks: